학술논문
Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18–55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial
Document Type
Article
Author
Chappell, Keith J.; Mordant, Francesca L.; Amarilla, Alberto A.; Modhiran, Naphak; Liang, Benjamin; Li, Zheyi; Wijesundara, Danushka K.; Lackenby, Julia A.; Griffin, Paul; Bennet, Jillian K.; Hensen, Luca; Zhang, Wuji; Nguyen, Thi H.O.; Tran, Mai H.; Tapley, Peter; Barnes, James; Reading, Patrick C.; Kedzierska, Katherine; Ranasinghe, Charani; Subbarao, Kanta; Watterson, Daniel; Young, Paul R.; Munro, Trent P.
Source
In eBioMedicine November 2023 97
Subject
Language
ISSN
2352-3964